Drug Profile
Peginterferon beta - Toray Industries
Alternative Names: PEG-IFN-beta - Toray; PEG-interferon-beta - Toray; Peginterferon-beta - Toray; PEGylated-interferon beta - Toray; TRK-560Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Toray
- Class Interferons
- Mechanism of Action Interferon beta stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer; Hepatitis B; Hepatitis C; Multiple sclerosis
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for preclinical development in Hepatitis-B in Japan (Parenteral)
- 11 Nov 2016 Pharmacodynamics data from preclinical studies in Hepatitis B infections presented at the 67th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD-2016)
- 29 Mar 2016 No recent reports on development identified - Phase-I for Hepatitis C (In volunteers) in Japan (Parenteral)